Delivery Order SPE2DB20D1100-SPE2DB23FC5K4

Award Date 7/12/23
Potential Completion Date 7/13/23
Potential Value $62
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $37,320 to Amerisourcebergen Drug Corporation for the supply of 4561664800 Atorvastatin 80 mg tablets. As the prime contractor, Amerisourcebergen will deliver 90 units of the generic cholesterol medication to a facility in Conshohocken, Pennsylvania, with performance required between August 1-2, 2023. The order was placed under an existing DLA contract vehicle to support the Department of Defense's medical...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $223,920 to Amerisourcebergen Drug Corporation for the provision of 4561970094 Atorvastatin 80 mg tablets, 90 count. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the generic cholesterol medication to locations within its Conshohocken, Pennsylvania facility in performance of the one day order. The Defense Logistics Agency routinely utilizes indefinite delivery/indefinite quantity contracts...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $318.60 to Amerisourcebergen Drug Corporation for the provision of 4561738047 Atorvastatin 40 mg tablets, 90 count. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the generic cholesterol medication to a location in Conshohocken, Pennsylvania in support of the Defense Logistics Agency's medical supply requirements. The delivery order was issued on August 8, 2023 under an existing...
The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $149,280 to supply 4561314141 Atorvastatin 80 mg tablets. As the prime contractor, Amerisourcebergen will deliver 90 counts of the generic cholesterol medication to its facility in Conshohocken, Pennsylvania under a one day period of performance from June 22 to June 23, 2023. The order is placed against an existing DLA contract vehicle to support the agency's medical supply...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-four thousand six hundred and sixty-four dollars to Amerisourcebergen Drug Corporation for the supply of atorvastatin tablets. Under the contract, Amerisourcebergen will deliver four hundred and fifty-six thousand two hundred and three tablets of atorvastatin, an 80mg cholesterol-lowering medication, to a facility in Conshohocken, Pennsylvania within a performance period spanning September 1st through...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $74,640 to Amerisourcebergen Drug Corporation for the supply of 4561902825 units of atorvastatin 80 mg tablets. As the prime contractor, Amerisourcebergen will deliver the generic cholesterol medication to its place of performance in Conshohocken, Pennsylvania within the period of performance from August 22 to August 23, 2023. The order was placed under an existing DLA contract vehicle in support of the Agency's...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $12,440 to Amerisourcebergen Drug Corporation for 4561732065 Atorvastatin 80 mg tablets. The order is for 90 tablets to be delivered to a facility in Conshohocken, Pennsylvania by August 8, 2023. Amerisourcebergen Drug Corporation will perform as the prime contractor, with its parent company listed as Amerisourcebergen Corporation. The Defense Logistics Agency is the funding agency for this delivery of...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $336 to Amerisourcebergen Drug Corporation for the supply of 500 tablets of 20mg atorvastatin. As the prime contractor, Amerisourcebergen will deliver the generic cholesterol-lowering medication to a facility in Conshohocken, Pennsylvania under a one-day period of performance beginning September 21, 2023. The order is placed against an existing DLA contract vehicle to support the agency's procurement of...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $242.76 to Amerisourcebergen Drug Corp for the supply of 1,000 tablets of 40mg atorvastatin. The order is to be performed in Conshohocken, Pennsylvania by July 24, 2023, with the Defense Logistics Agency as the funding agency. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, which will serve as the prime contractor to fulfill this order for the generic cholesterol medication. No...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $728 to Amerisourcebergen Drug Corporation for the supply of 80mg atorvastatin tablets. As the prime contractor, Amerisourcebergen will deliver 30-count bottles of the cholesterol-lowering medication to a facility in Conshohocken, Pennsylvania, with performance required between August 11-14, 2023. The order was placed under an existing DLA contract vehicle in support of the agency's medical supply...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB23FC5K4
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at $62,200 to Amerisourcebergen Drug Corporation for the provision of 4561479108 Atorvastatin 80 mg tablets in quantities of 90 tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the generic cholesterol medication to a location in Conshohocken, Pennsylvania in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified in the award provided. The single day period of performance from July 12 to July 13, 2023 suggests this delivery order was placed to meet an immediate requirement under the DLA's pharmaceutical supply contracts.

Generated 12/22/23, 2:07 PM